In vitro and in silico insights of Cupressus sempervirens, Artemisia absinthium and Lippia triphylla: Bridging traditional knowledge and scientific validation
dc.contributor.author | Zengin, Gökhan | |
dc.contributor.author | Mollica, Adriano | |
dc.contributor.author | Aktümsek, Abdurrahman | |
dc.contributor.author | Picot, Carene Marie Nancy | |
dc.contributor.author | Mahomoodally, Mohamad Fawzi | |
dc.date.accessioned | 2020-03-26T19:41:53Z | |
dc.date.available | 2020-03-26T19:41:53Z | |
dc.date.issued | 2017 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | Introduction: The search for new therapeutic agents for the management of diabetes mellitus type 2 (DMT2) and neurodegenerative disorders coupled with the rising number of patients suffering from these pathologies have attracted much interest. Traditionally, extracts from medicinal plants have been used to manage a number of ailments and still remain a potent source of new therapeutic agents. Methods: Therefore, the present study was undertaken to evaluate the in vitro antioxidant and enzyme (acetyl cholinesterase (AChE), butyryl cholinesterase (BChE), tyrosinase, alpha-amylase, and alpha-glucosidase) inhibitory potential of three medicinal plants (Cupressus sempervirens, Artemisia absinthium, and Lippia triphylla). The phenolic composition of the ethanolic extracts was also characterized using reversed-phase high-performance liquid chromatography (RP-HPLC). In silico molecular docking was used to investigate the possible interaction between active compounds and the studied enzymes. Results: C. sempervirens showed the highest inhibition rates against AChE, BChE, alpha-amylase, and alpha-glucosidase (2.47 mg galantamine equivalents (GALAE)/g extract, 2.98 mg GALAE/g extract, 1.61 mmol acarbose equivalents (ACAE)/g extract, and 1.86 mmol ACAE/g extract for respective enzymes). The plant extracts showed antioxidant power in the following order C. sempervirens > L. triphylla > A. absinthium. Protocatechuic acid, (+)-catechin, apigenin, and chlorogenic acid were identified in all the plant extracts. The best docking pose obtained for each bioactive compound against the enzymes was mostly stabilized via hydrogen bonds and pi-pi stacks. Conclusion: This study provides insight into the antioxidant capacity and the inhibitory potential of these medicinal plants against key enzymes linked to DMT2 and neurodegenerative disorders. | en_US |
dc.identifier.doi | 10.1016/j.eujim.2017.05.010 | en_US |
dc.identifier.endpage | 141 | en_US |
dc.identifier.issn | 1876-3820 | en_US |
dc.identifier.issn | 1876-3839 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 135 | en_US |
dc.identifier.uri | https://dx.doi.org/10.1016/j.eujim.2017.05.010 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/35197 | |
dc.identifier.volume | 12 | en_US |
dc.identifier.wos | WOS:000414230000019 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.language.iso | en | en_US |
dc.publisher | ELSEVIER SCIENCE INC | en_US |
dc.relation.ispartof | EUROPEAN JOURNAL OF INTEGRATIVE MEDICINE | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | Cupressus sempervirens | en_US |
dc.subject | Bioactive compounds | en_US |
dc.subject | Diabetes | en_US |
dc.subject | Neurodegenerative disorders | en_US |
dc.subject | Traditional medicine | en_US |
dc.subject | Antioxidant | en_US |
dc.subject | Molecular docking | en_US |
dc.subject | Lippia triphylla | en_US |
dc.title | In vitro and in silico insights of Cupressus sempervirens, Artemisia absinthium and Lippia triphylla: Bridging traditional knowledge and scientific validation | en_US |
dc.type | Article | en_US |